news

DCW Limited Q2 FY26 EBITDA Surges 51% YoY; H1 PAT Rises 360%, Driven By Specialty Segment Growth and Alternate Energy-Substitution Gains

Performance acceleration validates the strategy of portfolio refinement, leveraging Specialty Chemicals as a growth engine while extracting efficiency through cost…

8 months ago

Jungbunzlauer closes acquisition of Illinois facility to launch U.S. manufacturing operations

– Strategic investment enhances service to North American customers and supports rising market demand for high-quality ingredients – BASEL, Switzerland,…

8 months ago

Tenthpin Expands footprint in India

Launches Center for Life Sciences Cloud Solutions in Pune PUNE, India, Nov. 6, 2025 /PRNewswire/ -- Switzerland based Tenthpin Management Consultants,…

8 months ago

THE LEELA PALACES, HOTELS AND RESORTS EXPANDS ITS FOOTPRINT IN RAJASTHAN WITH THE SIGNING OF THE LEELA JAISALMER, A LUXURY DESERT RESORT AND SPA

Strengthens its presence in the state with its first Desert Resort and Spa, elevating the brand's leisure and cultural circuit…

8 months ago

Shining in Milan for Three Consecutive Years, TAILG Leads a New Wave in Global Electric Mobility

MILAN, Nov. 6, 2025 /PRNewswire/ -- On November 4, the world's top two-wheeler event — EICMA — opened in Milan.…

8 months ago

Cango Inc. Releases Letter to Shareholders

HONG KONG, Nov. 6, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today released a letter to shareholders at the one-year milestone…

8 months ago

Ampace Unveils Breakthroughs in E-Motorcycles and Battery Swap Solutions at EICMA

MILAN, Nov. 6, 2025 /PRNewswire/ -- Ampace, a globally leading lithium battery manufacturer, showcased its latest innovations at EICMA in…

8 months ago

BlueWillow Biologics Intranasal Bird Flu Vaccine Shows Signs of Broad Immune Response in Phase I Clinical Trial Published in Nature Communications

ANN ARBOR, Mich., Nov. 06, 2025 (GLOBE NEWSWIRE) -- BlueWillow Biologics, Inc., a clinical-stage biotech company pioneering the future of…

8 months ago

arcoris bio raises CHF 6.3 million seed round to advance next-generation biomarker technology for digital pathology

Schlieren, Switzerland, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Round co-led by Ventura Ace and ZEISS Ventures, with participation from Zürcher…

8 months ago